pravastatin has been researched along with Hyperlipoproteinemia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 8 (57.14) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, M; Hasegawa, A; Horimoto, M; Igarashi, K; Inoue, H; Takenaka, T | 1 |
| Hayashi, M; Ichihara, A; Kaneshiro, Y; Koura, Y; Saruta, T; Tada, Y | 1 |
| Gordon, BR; Levine, DM; Parker, TS; Rosenson, RS; Tangney, CC | 1 |
| Aihara, N; Horikawa, K; Kunita, T; Mizuno, T; Ochi, H; Takizawa, I; Tazuma, S; Teramen, K; Watanabe, T; Yamashita, Y | 1 |
| Ayada, Y; Hosomi, N; Ichihara, S; Kawanishi, K; Kitadai, M; Sada, Y; Satoh, K; Takahashi, T; Tsuda, Y; Yamamoto, M | 1 |
| Procházka, J; Růzek, V | 1 |
| De Gennes, JL; Grosgogeat, Y; Hadjiisky, P; Hermier, D; Truffert, J | 1 |
| Hosomi, N; Izumi, Y; Kitadai, M; Satoh, K; Takahashi, T; Tsuda, Y | 1 |
| Gerbes, AL; Parhofer, KG; Schwandt, P; Zachoval, R | 1 |
| Alaupovic, P; Collet, JP; Harvey, L; Leiter, L; McQueen, MJ; Schweitzer, M; Tessier, D; Vlahos, WD | 1 |
| Jansen, EH; Joles, JA; Koomans, HA; Van Tol, A | 1 |
| Hockwin, O; Schmidt, J; Schmitt, C | 1 |
| Murase, T | 1 |
| Saito, Y; Yoshida, S | 1 |
7 trial(s) available for pravastatin and Hyperlipoproteinemia
| Article | Year |
|---|---|
Long-term administration of pravastatin reduces serum lipoprotein(a) levels.
Topics: Aged; Cholesterol, LDL; Coronary Artery Disease; Drug Administration Schedule; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Lipoprotein(a); Male; Middle Aged; Pravastatin | 2003 |
Long-term effects of statins on arterial pressure and stiffness of hypertensives.
Topics: Anticholesteremic Agents; Arteriosclerosis; Blood Pressure; C-Reactive Protein; Cholesterol; Elasticity; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypertension; Indoles; Male; Middle Aged; Pravastatin; Prospective Studies; Pulsatile Flow; Simvastatin; Single-Blind Method | 2005 |
Elevated soluble tumor necrosis factor receptor levels in non-obese adults with the atherogenic dyslipoproteinemia.
Topics: Arteriosclerosis; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Male; Middle Aged; Pravastatin; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Simvastatin; Tumor Necrosis Factor Decoy Receptors | 2004 |
Effects of long-term treatment with low-dose pravastatin on biliary lipid and bile acid composition in patients with nonfamilial hyperlipoproteinemia.
Topics: Adult; Aged; Anticholesteremic Agents; Bile; Bile Acids and Salts; Ceruletide; Cholesterol; Dose-Response Relationship, Drug; Fatty Acids; Female; Gastrointestinal Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Lipid Metabolism; Lipids; Male; Middle Aged; Phosphatidylcholines; Pravastatin; Time Factors | 1995 |
Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.
Topics: Acyl Coenzyme A; Blood Viscosity; Cholesterol; Enzyme Inhibitors; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hyperlipoproteinemias; Lovastatin; Male; Middle Aged; Pravastatin; Simvastatin; Triglycerides | 1996 |
Short-term effects of statin therapy in patients with hyperlipoproteinemia after liver transplantation: results of a randomized cross-over trial.
Topics: Aged; Cholesterol; Cholesterol, LDL; Cross-Over Studies; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Pravastatin; Prospective Studies; Pyridines; Time Factors | 2001 |
A comparison of pravastatin and gemfibrozil in the treatment of dyslipoproteinemia in patients with non-insulin-dependent diabetes mellitus.
Topics: Aged; Apolipoproteins; Cholesterol, LDL; Cholesterol, VLDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Evaluation; Female; Follow-Up Studies; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Patient Compliance; Phenotype; Pravastatin; Treatment Outcome; Triglycerides | 2002 |
7 other study(ies) available for pravastatin and Hyperlipoproteinemia
| Article | Year |
|---|---|
Effect of medication with pravastatin sodium on hemorheological parameters in patients with hyperlipoproteinemia.
Topics: Cholesterol; Female; Fibrinogen; Hemorheology; Humans; Hyperlipoproteinemias; Male; Middle Aged; Pravastatin; Triglycerides | 1993 |
[Lipostat in the treatment of hyperlipoproteinemia].
Topics: Adult; Female; Humans; Hyperlipoproteinemias; Male; Middle Aged; Pravastatin | 1993 |
Effect of pravastatin, a HMG CoA reductase inhibitor, on blood lipids and aortic lipidosis in cholesterol-fed White Carneau pigeons.
Topics: Animals; Aorta; Cholesterol; Cholesterol, Dietary; Columbidae; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipoproteinemias; Lipids; Male; Pravastatin | 1993 |
Hyperlipoproteinemia in Nagase analbuminemic rats: effects of pravastatin on plasma (apo)lipoproteins and lecithin:cholesterol acyltransferase activity.
Topics: Animals; Apolipoproteins; Chromatography, Gel; Electrophoresis, Polyacrylamide Gel; Fatty Acids, Nonesterified; Female; Hyperlipoproteinemias; Phosphatidylcholine-Sterol O-Acyltransferase; Phospholipids; Pravastatin; Rats; Rats, Inbred Strains | 1991 |
[The HMG-CoA reductase inhibitors simvastatin and pravastatin. No indication for side effects in use on humans].
Topics: Adult; Cataract; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Lovastatin; Middle Aged; Pravastatin; Refraction, Ocular; Risk Factors; Simvastatin; Visual Acuity | 1991 |
[Hyperlipoproteinemia: classification and current problems].
Topics: Diet; Heptanoic Acids; Humans; Hyperlipoproteinemias; Lipoproteins; Naphthalenes; Pravastatin; Probucol; Specific Gravity | 1990 |
[Recent trend in the research of hyperlipidemia in Japan. Treatment of refractory hyperlipidemia].
Topics: Anticholesteremic Agents; Bezafibrate; Blood Component Removal; Cholesterol; Drug Therapy, Combination; Heptanoic Acids; Humans; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type V; Hyperlipoproteinemias; Naphthalenes; Pravastatin; Probucol; Triglycerides | 1989 |